High Utilizers of Health Care Resources: Results From the Multicenter Compact Study of Complications in Patients With Sickle Cell Disease and Utilization of Iron Chelation Therapy

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.834
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Effect of Iron Chelation Therapy on Overall Survival in Sickle Cell Disease and Β-Thalassemia: A Systematic Review

American Journal of Hematology
Hematology
2018English

Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use

Journal of the American Board of Family Medicine
EnvironmentalPublic HealthFamily PracticeOccupational Health
2020English

Health Care Resource Utilization Among Medicare Beneficiaries With Copd: Comparison of High and Low Utilizers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Lentiglobin Gene Therapy in Patients With Sickle Cell Disease: Updated Interim Results From HGB-206

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Study of Iron Profile in Sickle Cell Patients

Journal of Evolution of Medical and Dental Sciences
2018English

Role of Hydroxycarbamide in Prevention of Complications in Patients With Sickle Cell Disease

Therapeutics and Clinical Risk Management
2009English

Patterns of Liver Iron Accumulation in Sickle Cell Disease and Thalassaemia Patients With Iron Overload

European Journal of Haematology
MedicineHematology
2010English

Long-Term Persistency and Costs Associated With the Use of Iron Chelation Therapies in the Treatment of Sickle Cell Disease Within Medicaid Programs

Journal of Medical Economics
Health Policy
2012English

In Search of the Optimal Iron Chelation Therapy for Patients With Thalassemia Major

Haematologica
Hematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy